Treatment of patients with drug-resistance in economically developed countries.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000995:Antitubercular Agents / Q000008:administration & dosage; D003365:Costs and Cost Analysis; D003523:Cycloserine / Q000008:administration & dosage; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000008:administration & dosage; D005000:Ethionamide / Q000008:administration & dosage; D006801:Humans; D008826:Microbial Sensitivity Tests; D011718:Pyrazinamide / Q000008:administration & dosage; D012293:Rifampin / Q000008:administration & dosage; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014756:Viomycin / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D012293:Rifampin; D014756:Viomycin